CMDAT Research Foundation
This organization has already been registered
Someone in your organization has already registered and setup an account. would you like to join their team?Profile owner : d*********v@c***t.o*g
Mission Statement
We are a group of local and out of state medical doctors, scientists and volunteers. You've heard it before: "think globally, act locally" ... Well, when it comes to us, we think globally but we act locally and globally. We are small but efficient and our projects have both local and national impact. Our local health seminars have helped hundreds of low income families, women, refugees and minorities. Our research projects relate to such important issues as Alzheimer’s disease, head trauma, blindness, high altitude disease etc. which affect millions of people locally and worldwide. So thank you for supporting us!
About This Cause
We are providing free health seminars focused on various important health issues such as headaches (migraine), chronic pain issues, fibromyalgia, nutrition, stroke, osteoporosis, diabetes and diabetic neuropathy etc. We are partnering with many local organizations and communities such as Celebration Community Church, Virginia Village Library, African Community Center, Colorado Heights University, Rocky Mountain Communities, YMCA, Inner City Clinic etc. to reach as many low income families, women, refugees and minorities as possible. Our high altitude research projects propose that high altitude can potentially trigger many negative post-head trauma outcomes such as post-traumatic headache, depression, or post-traumatic stress disorder. We are also suggesting that prevalence of ocular and optic injuries, as well as various complications following trauma (i.e. vision impairment) are likely to be influenced by geographic altitude. Our previous project concluded that regional differences in the rates of Alzheimer’s disease can be explained, in part, by the earth landscape (i.e., high altitude) Our theoretical research attempted to explain some sporadic cases of Alzheimer’s disease in the presence of minimal damage from atherosclerosis in this area and this research would open up new avenues for prevention of sporadic Alzheimer’s disease Why is this important? For example, when it comes to Alzheimer’s disease, it is the sixth leading cause of death in the United States. The Alzheimer’s Association 2015 Facts and Figures report estimates that 1 in 9 Americans have Alzheimer’s disease, totaling 5.3M Americans. It is projected that 473,000 people age 65+ will develop Alzheimer’s disease in the US in 2015. People are living longer, and as the number of older Americans grows, the incidence of Alzheimer’s disease will grow. Every 67 seconds, someone in the U.S. develops Alzheimer’s disease; by 2050 it will be every 33 seconds. By 2050, it is estimated that 13.8M people age 65+ will have Alzheimer’s disease. In total, Alzheimer’s disease-related health care, long-term care, and hospice are estimated to cost the U.S. $226B in 2015; By 2050, this will go up to more than $1T.There are only a handful of therapeutics available, but even these treatments only target symptoms and provide short-term and often incomplete relief. No therapeutics can delay, prevent, or reverse the onset of Alzheimer’s disease. In fact, there has been a 99.6% failure rate in getting Alzheimer’s disease drugs from the benchtop to the bedside. There is an urgent need to develop new research directions and therapeutics.